| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | TRX818 |
|---|
| Description | TRX818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities. TRX-818, upon oral administration appears to induce cancer cell apoptosis and inhibits cancer cell proliferation. TRX818 also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures. MW: 393.21. Purity ≥98% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Sodium (2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin-5-yl)phosphonate |
|---|
| Gene, Accession, CAS # | CAS: 1256037-58-7 |
|---|
| Catalog # | B1223-25 |
|---|
| Price | |
|---|
| Order / More Info | TRX818 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|